Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Spiros products progressing through pipeline

March 10, 1997

New PDE III/IV inhibitor described

March 10, 1997

HLE inhibitors from P&U

March 5, 1997

Antiallergic compounds disclosed by Meiji Seika

Feb. 28, 1997

PathoGenesis to seek approval for tobramycin

Feb. 27, 1997

Positive clinical results for inhaled indomethacin

Feb. 27, 1997

Mediator release inhibitors described by French investigators

Feb. 27, 1997

Hisamitsu reports antiallergic agents

Feb. 26, 1997

HPA effects of new formulation of Azmacort

Feb. 25, 1997

Dose-response study of CFC-free Azmacort formulation in adult asthmatics

Feb. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...